A Cyclic Peptide Mimic of the β-Amyloid Binding Domain on Transthyretin-Reference-Cited by-同舟云学术

A Cyclic Peptide Mimic of the β-Amyloid Binding Domain on Transthyretin

Published:2015-03-09 Issue:5 Volume:6 Page:778-789
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Cho Patricia Y.¹,Joshi Gururaj¹,Boersma Melissa D.¹,Johnson Jeffrey A.¹,Murphy Regina M.¹

Affiliation:

1. Department of Chemical and Biological Engineering, ‡School of Pharmacy, and §Biotechnology Center, University of Wisconsin—Madison, Madison, Wisconsin 53706, United States

Funder

National Institute on Aging

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/cn500272a

Reference38 articles.

1. Amyloid β-Protein Assembly and Alzheimer Disease

2. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

3. A specific amyloid-β protein assembly in the brain impairs memory

4. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

5. The Future of Peptide-based Drugs

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteolytically Stable Diaza-Peptide Foldamers Mimic Helical Hot Spots of Protein–Protein Interactions and Act as Natural Chaperones;Journal of Medicinal Chemistry;2023-08-26

2. APPI-Derived Cyclic Peptide Enhances Aβ42 Aggregation and Reduces Aβ42-Mediated Membrane Destabilization and Cytotoxicity;ACS Chemical Neuroscience;2023-08-14

3. Rationally designed cyclic peptides and nanomaterials as ‘next-generation’ anti-amyloid therapeutics;Journal of Materials Science;2023-06

4. Development of a Potent Cyclic Peptide Inhibitor of the nNOS/PSD-95 Interaction;Journal of Medicinal Chemistry;2022-12-29

5. Optimizing Epitope Conformational Ensembles Using α-Synuclein Cyclic Peptide “Glycindel” Scaffolds: A Customized Immunogen Method for Generating Oligomer-Selective Antibodies for Parkinson’s Disease;ACS Chemical Neuroscience;2022-07-15